Mitochondrial efficiency, cellular signaling and the GH/IGF-1 axis. Therapies designed to defend healthspan and slow age-related decline.
Deeper, more restorative sleep
Selective ghrelin/GHS-R1a agonist. Triggers GH release without significant cortisol or prolactin elevation.
Prescription-only; compounded.
Cautions: Active malignancy · Diabetes: monitor glucose
Supports lean muscle maintenance
GHRH analog with extended half-life. Frequently paired with ipamorelin for additive pulse amplitude.
Prescription-only; compounded.
Cautions: Active malignancy · Severe acute illness · DAC variant carries higher edema risk
Strong growth-hormone pulse
Potent GHS-R1a agonist with additional cardioprotective signaling via CD36.
Research / compounding only.
Cautions: Tachyphylaxis with chronic use · Mild cortisol/prolactin rise vs ipamorelin
Improves how your body uses insulin
Mitochondrial-derived 16-aa peptide. Activates AMPK, improves insulin sensitivity, and supports mitochondrial biogenesis.
Research / compounding.
Cautions: Investigational; long-term human data lacking
Supports mitochondrial energy efficiency
Cardiolipin-binding tetrapeptide that stabilizes the inner mitochondrial membrane and restores ATP production.
Investigational drug. Available off-label via specialty compounding in some regions.
Cautions: Injection-site reactions · Investigational
Supports cellular energy production
Replenishes cellular NAD+ pool, a cofactor for sirtuins, PARPs, and mitochondrial energy metabolism.
Compounded injectable (NAD+); NR/NMN often sold as dietary supplements (status varies).
Cautions: Flushing during IV infusion · Cost
May improve sleep quality
Synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly). Animal data suggest telomerase upregulation and circadian normalization.
Research only in most countries.
Cautions: Limited Western trial data
Cellular protection (preclinical)
Mitochondrial-derived 24-aa peptide with cytoprotective and metabolic signaling activity.
Research only.
Cautions: Investigational
Supports muscle and tissue repair
Long-acting recombinant IGF-1 analog with reduced IGFBP binding. Direct anabolic and tissue-repair signaling.
Research / compounding only.
Cautions: Hypoglycemia risk · Avoid in any active or prior malignancy · Requires close clinical supervision
Every protocol is reviewed by an independent, licensed physician before any recommendation is issued.
We only prescribe therapies that are legally available where you live, through compliant pharmacies.
Your medical intake and blood panel are screened for conditions that would make a peptide unsafe.
Protocols are adjusted based on objective lab change. If a marker is not improving, we change the plan.
The €90 intake returns a clinician-reviewed brief in 48 hours. Full protocol · €320.
Start assessment →